CLLS
Price
$3.10
Change
+$0.05 (+1.64%)
Updated
Sep 11 closing price
Capitalization
320.81M
58 days until earnings call
Intraday BUY SELL Signals
PMVP
Price
$1.40
Change
-$0.04 (-2.78%)
Updated
Sep 11 closing price
Capitalization
75.91M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLLS vs PMVP

CLLS vs PMVP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLLS vs. PMVP commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Hold and PMVP is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($321M) has a higher market cap than PMVP($75.9M). PMVP YTD gains are higher at: 12.000 vs. CLLS (-35.950). CLLS has higher annual earnings (EBITDA): -38.52M vs. PMVP (-79.54M). CLLS has more cash in the bank: 167M vs. PMVP (79.4M). PMVP has less debt than CLLS: PMVP (217K) vs CLLS (84.6M). CLLS has higher revenues than PMVP: CLLS (56.6M) vs PMVP (0).
CLLSPMVPCLLS / PMVP
Capitalization321M75.9M423%
EBITDA-38.52M-79.54M48%
Gain YTD-35.95012.000-300%
P/E RatioN/AN/A-
Revenue56.6M0-
Total Cash167M79.4M210%
Total Debt84.6M217K38,986%
FUNDAMENTALS RATINGS
CLLS vs PMVP: Fundamental Ratings
CLLS
PMVP
OUTLOOK RATING
1..100
6993
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5542
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (45) in the Biotechnology industry is in the same range as PMVP (56) in the null industry. This means that CLLS’s stock grew similarly to PMVP’s over the last 12 months.

CLLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PMVP (100) in the null industry. This means that CLLS’s stock grew similarly to PMVP’s over the last 12 months.

CLLS's SMR Rating (98) in the Biotechnology industry is in the same range as PMVP (98) in the null industry. This means that CLLS’s stock grew similarly to PMVP’s over the last 12 months.

PMVP's Price Growth Rating (42) in the null industry is in the same range as CLLS (55) in the Biotechnology industry. This means that PMVP’s stock grew similarly to CLLS’s over the last 12 months.

PMVP's P/E Growth Rating (80) in the null industry is in the same range as CLLS (100) in the Biotechnology industry. This means that PMVP’s stock grew similarly to CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLLSPMVP
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CLLS: $3.10 vs. PMVP: $1.40)
Brand notoriety: CLLS and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 484% vs. PMVP: 115%
Market capitalization -- CLLS: $320.81M vs. PMVP: $75.91M
CLLS [@Biotechnology] is valued at $320.81M. PMVP’s [@Biotechnology] market capitalization is $75.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 0 FA rating(s) are green while PMVP’s FA Score has 0 green FA rating(s).

  • CLLS’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLLS and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 6 bullish TA indicator(s).

  • CLLS’s TA Score: 5 bullish, 5 bearish.
  • PMVP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than CLLS.

Price Growth

CLLS (@Biotechnology) experienced а -4.32% price change this week, while PMVP (@Biotechnology) price change was +8.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CLLS is expected to report earnings on Nov 09, 2026.

PMVP is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CLLS
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAYX12.69N/A
N/A
Invesco Income Advantage U.S. Fund Y
MSERX9.02N/A
N/A
MassMutual Small Cap Growth Eq R4
EEQAX11.15N/A
N/A
BTS Enhanced Equity Income A
EZTGX61.12N/A
N/A
Eaton Vance Tx-Mgd Growth 1.2 C
LAFTX22.48N/A
N/A
Lord Abbett Affiliated R5

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+1.64%
SLN - CLLS
43%
Loosely correlated
-2.18%
MDGL - CLLS
40%
Loosely correlated
+0.26%
PMVP - CLLS
38%
Loosely correlated
-2.78%
AXON - CLLS
36%
Loosely correlated
+0.10%
TGTX - CLLS
36%
Loosely correlated
-2.71%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-2.78%
CLLS - PMVP
39%
Loosely correlated
+1.64%
MTVA - PMVP
35%
Loosely correlated
-5.14%
AXON - PMVP
31%
Poorly correlated
+0.10%
ARRY - PMVP
31%
Poorly correlated
+1.54%
VCYT - PMVP
30%
Poorly correlated
-2.76%
More